RxDoctor Payments DataLook up a doctor →

Nisreen Haideri, MD

Medical Oncology · Overland Park, KSNPI 1487682092

Payments from drug & device makers

$1,179,433in general payments, 2019–2025

Across 291 payments — averaging $4053.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$422K
  • Boehringer Ingelheim$299K
  • Seagen Inc.$234K
  • Novartis$151K
  • Clovis Oncology, Inc.$52K
  • Genentech, Inc.$16K
  • plus $6K from 17 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,179,433 in reported general payments places this provider in the 75th percentile of 25 medical oncology providers in Kansas.

See all medical oncology providers in Kansas

Medicare billing

Part B allowed, 2024
$54,801
Medicare patients
265
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →